Le Lézard32m
U.S. FDA Grants Full Approval of Deciphera's ROMVIMZAtm (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZAtm (vimseltinib), a kinase ...
Hosted on MSN21m
Researchers Develop Innovative Treatment for Malaria
An international team of researchers have introduced a groundbreaking drug, known as the covalent kinase inhibitor, which shows promise in combating treatment-resistant malaria.Developed by chemists ...
Science Daily25m
New blood-clotting disorder identified
Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...
Le Lézard50m
HARTLINE BARGER LLP PROVIDES NOTICE OF DATA EVENT
Hartline Barger LLP ("Hartline Barger"), a law firm that practices in the areas of personal injury, commercial, construction, franchise, healthcare, employment, labor, and product liability litigation ...